Mannitol Versus Supportive Care in Ciguatera Fish Poisoning
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02570971|
Recruitment Status : Unknown
Verified October 2015 by University of South Florida.
Recruitment status was: Not yet recruiting
First Posted : October 7, 2015
Last Update Posted : October 7, 2015
|Condition or disease||Intervention/treatment||Phase|
|Ciguatoxin||Drug: Mannitol||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||200 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Mannitol Versus Supportive Care in Ciguatera Fish Poisoning: A Randomized Control Trial|
|Study Start Date :||October 2015|
|Estimated Primary Completion Date :||June 2018|
No Intervention: Control
Patients will receive supportive care measures.
Patients will receive 500mL of 20% mannitol
- Symptom score [ Time Frame: 24 hours ]Covers a variety of neurological and gastrointestinal symptoms on a 0-4 score
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02570971
|Contact: Michael Butterfield, MD MS MPHemail@example.com|